A novel nucleoside analog, 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro

Keyphrases

• Ribavirin 100%
• Flavivirus 100%
• Nucleoside Analogues 100%
• Dengue Virus Serotype 2 100%
• 1,2,4-triazole 100%
• Ethynyl 100%
• Antiviral Activity 33%
• Virus 33%
• Azoles 33%
• Antiretroviral Therapy 33%
• Mechanism of Action 33%
• Dengue 33%
• Flavivirus Infection 33%
• Cultured Cells 33%
• Vero Cells 33%
• Infected Cells 33%
• Guanosine 33%
• Imidazole 33%
• Drug Candidates 33%
• Effective Concentration 33%
• Serotype 1 33%
• Promising Drug 33%
• Yellow Fever 33%
• Serotype 3 33%
• West Nile Fever 33%
• Emerging Flavivirus 33%
• Serotype 4 33%
• DENV Serotypes 33%
• Langat Virus 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Nucleoside Analog 100%
• Flavivirus 100%
• Dengue Virus 100%
• Triazole 100%
• Ribavirin 75%
• Antiviral Therapy 25%
• Yellow Fever 25%
• Langat Virus 25%
• Antivirus Agent 25%
• Dengue 25%
• Flavivirus Infection 25%
• West Nile Fever 25%
• Guanosine Triphosphate 25%
• Guanosine 25%
• Imidazole 25%
• EC50 25%
• Pyrrole 25%